Zyvox — CareFirst (Caremark)

Initial criteria

• The patient has ANY of the following:
• • An infection caused by vancomycin-resistant Enterococcus faecium including cases with concurrent bacteremia.
• • A nosocomial (institution-acquired) pneumonia caused by Staphylococcus aureus (methicillin-susceptible and -resistant isolates) or Streptococcus pneumoniae.
• • Community-acquired pneumonia caused by Streptococcus pneumoniae, including cases with concurrent bacteremia, or Staphylococcus aureus (methicillin-susceptible isolates only).
• • A complicated skin and skin structure infection including diabetic foot infections, without concomitant osteomyelitis, caused by Staphylococcus aureus (methicillin-susceptible and -resistant isolates), Streptococcus pyogenes, or Streptococcus agalactiae.
• • An uncomplicated skin and skin structure infection caused by Staphylococcus aureus (methicillin-susceptible isolates only) or Streptococcus pyogenes.
• The infection is proven or strongly suspected to be caused by susceptible bacteria.
• The patient will use the requested drug orally or intravenously.

Approval duration

28 days